Pomegranate compound urolithin A shows 80% improvement in hard-to-treat heart failure

Nearly 500,000 people in the UK with heart failure with preserved ejection fraction experience breathlessness, fatigue, reduced exercise ability and poor quality of life due to limited treatment options.
Contact Us FAQ